Nasal polysaccharides-glucose regulator microparticles: Optimization, tolerability and antidiabetic activity in rats

Carbohydrate Polymers

Volumn 108, Issue 1, 2014, Pages 257-265

  Elmowafy, Enas ^a   Osman, Rihab ^a   El Shamy, Abd El Hameed A ^a   Awad, Gehanne A S ^a  

^a African Union Organization St Abbassia   (Egypt)

Author keywords

Antidiabetic; Insufflator; Microparticles; Nasal powder; Polysaccharides; Spray drying

Indexed keywords

GLUCOSE; OPTIMIZATION; POWDERS; RATS; SPRAY DRYING;

ANIONIC POLYSACCHARIDES; ANTI DIABETICS; ANTIDIABETIC ACTIVITY; CYTOCOMPATABILITY; INSUFFLATOR; MICRO-PARTICLES; MUCOADHESIVE MICROPARTICLES; SPRAY-DRIED POWDERS;

POLYSACCHARIDES;

RATTUS;

ANTIDIABETIC AGENT; CARBAMIC ACID DERIVATIVE; GLUCOSE BLOOD LEVEL; PIPERIDINE DERIVATIVE; REPAGLINIDE;

ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; INTRANASAL DRUG ADMINISTRATION; MALE; NOSE MUCOSA; PROCEDURES; RAT;

ADMINISTRATION, INTRANASAL; ANIMALS; BLOOD GLUCOSE; CARBAMATES; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; MALE; NASAL MUCOSA; PIPERIDINES; RATS;

EID: 84899409776     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.02.064     Document Type: Article

References (41)

1. M. Abu Abeeleh, Z.B. Ismail, K.R. Alzaben, S.A. Abu-Halaweh, M.K. Al-Essa, and J. Abuabeeleh et al. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: A comparison between 2 strains of rats European Journal of Scientific Research 32 3 2009 398 402
2. A. Alhalaweh, S. Andersson, and S.P. Velaga Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery European Journal of Pharmaceutical Sciences 38 3 2009 206 214
3. V.G. Anitha, V.V. Deepagan, Divya Rani, S.V. Deepthy Menon, R. Nair, and Jayakumar Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles Carbohydrate Polymers 84 2011 1158 1211
4. C. Arama, C. Nicolescu, A. Nedelcu, and C.-M. Monciu Synthesis and characterization of the inclusion complex between repaglinide and sulfobutylether-b-cyclodextrin (Captisol) Journal of Inclusion Phenomena and Macrocyclic Chemistry 70 3-4 2011 421 428
5. J.F. Blickle Meglitinide analogues: A review of clinical data focused on recent trials Diabetes Metabolism 32 2006 113 120
6. H. Bshara, R. Osman, S. Mansour, and A. El-Shamy Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats Carbohydrate Polymers 99 2014 297
7. F. Buttini, P. Colombo, A. Rossi, F. Sonvico, and G. Colombo Particles and powders: Tools of innovation for non-invasive drug administration Journal of Controlled Release 161 2012 693 702
8. S. Cao, X. Rena, Q. Zhanga, E. Chena, F. Xua, and J. Chena et al. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate International Journal of Pharmaceutics 365 2009 109 115
9. K.H. Chen, M. Di Sabatino, B. Albertini, N. Passerini, and V.L. Kett The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA European Journal of Pharmaceutical Sciences 50 2013 312 322
10. N.Y. Chew, P. Tang, H.K. Chan, and J.A. Raper How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharmaceutical Research 22 2005 148 152 (Pubitemid 40558157)
11. D.O. Corrigan, O.I. Corrigan, and A.M. Healy Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers International Journal of Pharmaceutics 322 2006 22 30 (Pubitemid 44331521)
12. E.M. Elmowafy, G.A. Awad, S. Mansour, and A. El-Shamy Release mechanisms behind polysaccharides-based famotidine controlled release matrix tablets AAPS PharmSciTech 9 4 2008 1230 1239
13. E. Gavini, G. Rassu, C. Muzzarelli, M. Cossu, and P. Giunchedi Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide European Journal of Pharmaceutics and Biopharmaceutics 68 2008 245 252
14. W.R. Gombotz, and S.F. Wee Protein release from alginate matrices Advanced Drug Delivery Reviews 31 1998 267 285 (Pubitemid 28191869)
15. L. Illum Nasal drug delivery - Recent developments and future prospects Journal of Controlled Release 161 2012 254 263
16. S. Jain, and S. Saraf Repaglinide-loaded long-circulating biodegradable nanoparticles: Rational approach for the management of type 2 diabetes mellitus Journal of Diabetes 1 1 2009 29 35
17. M. Jalalipour, K. Gilani, H. Tajerzadeh, A.R. Najafabadi, and M. Barghi Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents International Journal of Pharmaceutics 352 2008 209 216
18. S.K.S. Kushwaha, R.K. Keshari, and A.K. Rai Advances in nasal trans-mucosal drug delivery Journal of Applied Pharmaceutical Science 1 7 2011 21 28
19. T.P. Learoyd, J.L. Burrows, E. French, and P.C. Seville Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate European Journal of Pharmaceutics and Biopharmaceutics 68 2008 224 234
20. C. Liu, K.G.H. Desai, X. Tang, and X. Chen Drug release kinetics of spray-dried chitosan microspheres Drying Technology 24 2006 769 776 (Pubitemid 43820929)
21. S.S. Lund, L. Tarnow, C.D.A. Stehouwer, C.G. Schalkwijk, M. Frandsen, and U.M. Smidt et al. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: Results from a randomized crossover trial Diabetes, Obesity and Metabolism 9 3 2007 394 407 (Pubitemid 46502060)
22. H.S. Mahajan, and S.G. Gattini Gellan gum based microparticles of metoclopromide hydrochloride for intranasal delivery: Development and evaluation Chemical and Pharmaceutical Bulletin 57 4 2009 388 392
23. C. Makino, H. Sakai, and A. Yabuki Nateglinide controlled release tablet containing compressionable enteric coated granules Chemical and Pharmaceutical Bulletin 58 9 2010 1136 1141
24. Z. Mandić, and V. Gabelica Ionization, lipophilicity and solubility properties of repaglinide Journal of Pharmaceutical and Biomedical Analysis 41 3 2006 866 871
25. D. Manzella, A.M. Abbatecola, R. Grella, and G. Paolisso Repaglinide administration improves brachial reactivity in type 2 diabetic patients Diabetes Care 28 2 2005 366 371 (Pubitemid 40170941)
26. M. Mark, and w. Grell Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs British Journal of Pharmacology 121 1997 1597 1604 (Pubitemid 27343385)
27. R.K. Mishra, A. Anisb, S. Mondalb, M. Dutta, and A.K. Banthiab Preparation and characterization of amidated pectin based polymer electrolyte membranes Chinese Journal of Polymer Science 27 5 2009 639 646
28. M. Nasr, G.A.S. Awad, S. Mansour, I. Taha, A. Elshamy, and N.D. Mortada Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting European Journal of Pharmaceutics and Biopharmaceutics 79 3 2011 601 611
29. R. Osman, P.L. Kan, G.A.S. Awad, N. Mortada, A. EL-Shamy, and O. Alpar Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity International Journal of Pharmaceutics 449 2013 44 58
30. N. Pachisia, and S.S. Agrawal Formulation, development and evaluation of transdermal drug delivery system of glimepiride International Journal of Pharmacy and Pharmaceutical Science Research 2 1 2012 1 8
31. S.B. Patil, and K.K. Sawant Chitosan microspheres as a delivery system for nasal insufflation Colloids and Surfaces B: Biointerfaces 84 2011 384 389
32. L. Pereswetoff-Morath, and P. Edman Dextran microspheres as a potential nasal drug delivery system for insulin - In vitro and in vivo properties International Journal of Pharmaceutics 124 1995 37 44
33. Plucinski, G., & Rezaizn-Yazdi, M. (2009). Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same. US Patent 0318502, 1-9.
34. G. Rathnam, P. Balasubramani, and A. Saravanakumar Nasal drug delivery of anti-diabetic drug repaglinide using biodegradable starch microspheres International Journal of Pharmaceutical Sciences and Research 2 4 2011 940 947
35. D. Sensoy, E. Cevher, A. SarIcI, M. YIlmaz, A. Ozdamar, and N. Bergisadi Bioadhesive sulfacetamide sodium microspheres: Evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model European Journal of Pharmaceutics and Biopharmaceutics 72 3 2009 487 495
36. Staniforth, J.N. (2002). Powders comprising antiadherant materials for use in dry powder inhalers. USA 6,475,523.
37. S. Upadhyay, A. Parikh, P. Joshi, U.M. Upadhyay, and N.P. Chotai Intranasal drug delivery system - A glimpse to become maestro Journal of Applied Pharmaceutical Science 1 3 2011 34 44
38. M.T. Vidgren, and H. Kublik Nasal delivery systems and their effect on deposition and absorption Advanced Drug Delivery Reviews 29 1998 157 177 (Pubitemid 28044092)
39. V. Vijayan, K. Ravindra Reddy, S. Sakthivel, and C. Swetha Optimization and characterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patches: In vitro and in vivo studies Colloids and Surfaces B: Biointerfaces 111 2013 150 155
40. P.J. Watts, and A. Smith PecSys: In situ gelling system for optimised nasal drug delivery Expert Opinion in Drug Delivery 6 2009 543 552
41. V.K. Yadav, B. Kumar, S.K. Prajapati, and K. Shafaat Design and evaluation of mucoadhesive microspheres of repaglinide for oral controlled release International Journal of Drug Delivery 3 2011 357 370